Each has its own dose-titration schedule, efficacy data, side effect profile, and patient suitability
Clinical trials reveal dose-dependent nausea rates for Wegovy's active ingredient, semaglutide: Nausea typically peaks during dose escalation and subsides as the body adapts
Additionally, large and long-term studies are also ongoing to provide more definitive results about the correlation between semaglutide use and cancer
The National Institutes of Health (NIH) explains, GLP-1 (Glucagon-Like Peptide-1) is a hormone that regulates blood sugar and appetite by triggering insulin release and slowing digestion, creating lasting fullness. 1 GLP-1 receptors are present throughout the body, including the brain, GI tract, and pancreas
For blood sugar control, they work by increasing the release of insulin and reducing glucagon after you eat